BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 1350 | Download: 755
Publication Name World Journal of Clinical Oncology
Manuscript ID 8469
Country United States
Received
2013-12-28 15:59
Peer-Review Started
2013-12-28 20:33
To Make the First Decision
2014-03-12 17:03
Return for Revision
2014-03-21 09:11
Revised
2014-04-11 03:41
Second Decision
2014-05-14 16:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-14 16:39
Articles in Press
2014-05-23 09:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-24 14:15
Publish the Manuscript Online
2014-08-01 16:16
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Update on prevention and screening of cervical cancer
Manuscript Source Invited Manuscript
All Author List Shaniqua L McGraw and Jeanne M Ferrante
Funding Agency and Grant Number
Corresponding Author Jeanne M Ferrante, MD, MPH, Department of Family Medicine and Community Health, Rutgers-Robert Wood Johnson Medical School, Somerset, New Jersey 08873, United States. jeanne.ferrante@rutgers.edu
Key Words Cervical cancer; Cancer screening; Pap smear; Human papillomavirus; Papillomavirus vaccines
Core Tip Screening is the best method to prevent cervical cancer. Screening strategies should weigh the benefits and risks of screening to avoid discovery and needless treatment of transient human papillomavirus (HPV) infections. Current United States guidelines recommend Pap smear screening with conventional or liquid-based method no frequent than every 3 years, or every 5 years in women greater than age of 30 if done in conjunction with HPV testing. Screening is not recommend in females younger than 21 years, regardless of age at initiation of sex. In this population, options for prevention include HPV vaccination and decreasing other risk factors associated with HPV infection.
Publish Date 2014-08-01 16:16
Citation McGraw SL, Ferrante JM. Update on prevention and screening of cervical cancer. World J Clin Oncol 2014; 5(4): 744-752
URL http://www.wjgnet.com/2218-4333/full/v5/i4/744.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i4.744
Full Article (PDF) WJCO-5-744.pdf
Full Article (Word) WJCO-5-744.doc
Manuscript File 8469-Review.docx
Answering Reviewers 8469-Answering reviewers.pdf
Copyright License Agreement 8469-Copyright assignment.pdf
Peer-review Report 8469-Peer review(s).pdf
Scientific Editor Work List 8469-Scientific editor work list.pdf